PTN and metastatic neoplasm: Consequently, blocking PTN in combination with anti–PD-1 therapy and Abraxane in mice with established TNBC metastatic disease had a significant therapeutic benefit, especially compared with anti–PD-1 plus Abraxane alone, which is currently being used to treat metastatic TNBC patients.